| FWWNX | IPOYX | FWWNX / IPOYX | |
| Total Expense Ratio | 0.63 | 1.05 | 60% |
| Annual Report Gross Expense Ratio | 0.63 | 1.49 | 42% |
| Fund Existence | 5 years | 22 years | - |
| Gain YTD | 28.245 | 26.204 | 108% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 76.3B | 696M | 10,963% |
| Annual Yield % from dividends | 0.95 | 2.65 | 36% |
| Returns for 1 year | 21.65 | 25.64 | 84% |
| Returns for 3 years | 52.03 | 34.27 | 152% |
| Returns for 5 years | 28.35 | -0.09 | -30,803% |
| Returns for 10 years | N/A | 83.40 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IQSI | 35.04 | 0.18 | +0.51% |
| NYLI Candriam International Equity ETF | |||
| VXUS | 75.82 | 0.29 | +0.38% |
| Vanguard Total International Stock ETF | |||
| IBBQ | 27.58 | 0.07 | +0.24% |
| Invesco Nasdaq Biotechnology ETF | |||
| FNOV | 53.91 | 0.01 | +0.02% |
| FT Vest US Equity Buffer ETF Nov | |||
| SMCY | 11.00 | -0.24 | -2.14% |
| YieldMax SMCI Option Income Strategy ETF | |||